Roles of chemokines and receptor polarization in NK-target cell interactions.
We report that the ability of NK cells to produce chemokines is increased in NK-target cell conjugates. The chemokines produced play a critical role in the polarization and recruitment of NK cells as well as in the NK effector-target cell conjugate formation. Chemokines induce the formation of two specialized regions in the NK cell: the advancing front or leading edge, where chemokine receptors CCR2 and CCR5 cluster, which might guide the cells toward the chemotactic source, and the uropod, where adhesion molecules ICAM-1 and -3 are redistributed. NK cell polarity was intrinsically involved in conjugate formation. The redistribution of both adhesion receptors and CCR was preserved during the formation of NK-target cell conjugates. Time-lapse videomicroscopy studies of the formation of effector-target conjugates showed that morphologic poles are also functionally distinct; while the binding to target cells was preferentially mediated through the leading edge, the uropod was found at the rear of migrating NK cells and recruited additional NK cells to the vicinity of K562 target cells. Inhibition of cell polarization and adhesion receptor redistribution blocked the formation of NK-K562 cell conjugates and the cytotoxic activity of NK cells. We discuss the implication of NK-cell polarization in the development of cytotoxic responses.
Nieto
M
M
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Navarro
F
F
Perez-Villar
J J
JJ
del Pozo
M A
MA
González-Amaro
R
R
Mellado
M
M
Frade
J M
JM
Martínez-A
C
C
López-Botet
M
M
Sánchez-Madrid
F
F
D015703:Antigens, CD; D000943:Antigens, Differentiation; D015815:Cell Adhesion Molecules / Q000502:physiology; D002450:Cell Communication / Q000276:immunology; D002451:Cell Compartmentation / Q000276:immunology; D016764:Cell Polarity / Q000276:immunology; D002478:Cells, Cultured; D018925:Chemokines / Q000378:metabolism / Q000502:physiology*; D002634:Chemotaxis, Leukocyte / Q000276:immunology; D018920:Coculture Techniques; D003593:Cytoplasm / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007111:Immunity, Cellular; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism* / Q000502:physiology; D004915:Leukemia, Erythroblastic, Acute; D011940:Receptor Aggregation / Q000276:immunology*; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D014407:Tumor Cells, Cultured
D015703:Antigens, CD; D000943:Antigens, Differentiation; D015815:Cell Adhesion Molecules; D018925:Chemokines; C483616:ICAM3 protein, human; D019707:Receptors, Chemokine